2025-08-29 17:10:02
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Strides Pharma Science consolidated Q3FY22 loss at Rs. 121.67 crores
Posted On : 2022-02-10 13:47:11( TIMEZONE : IST )
Strides Pharma Science Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 804.582 crores during the period ended December 31, 2021 as compared to Rs. 743.683 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -121.671 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -162.559 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -13.55 for the period ended December 31, 2021 as compared to Rs. -18.12 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 804.582 crs | ₹743.683 crs |  8.19% |
| Net Profit | ₹-121.671 crs | ₹-162.559 crs |  25.15% |
| EPS | ₹-13.55 | ₹-18.12 | 25.22% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 804.582 crores during the period ended December 31, 2021 as compared to Rs.845.225 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-121.671 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.37.847 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-13.55 for the period ended December 31, 2021 as compared to Rs.4.22 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 804.582 crs | ₹845.225 crs |  -4.81% |
| Net Profit | ₹-121.671 crs | ₹37.847 crs | -421.48% |
| EPS | ₹-13.55 | ₹4.22 | -421.09% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.2250.163 crores during the 9 Months period ended December 31, 2021 as compared to Rs.2445.756 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-489.430 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.222.356 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.-54.54 for the 9 Months period ended December 31, 2021 as compared to Rs.24.79 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹2250.163 crs | ₹2445.756 crs | -8.00% |
| Net Profit | ₹-489.430 crs | ₹222.356 crs | -320.11% |
| EPS | ₹-54.54 | ₹24.79 | -320.01% |
Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 395.10 as compared to the previous close of Rs. 393.75. The total number of shares traded during the day was 13102 in over 413 trades.
The stock hit an intraday high of Rs. 399.00 and intraday low of 390.40. The net turnover during the day was Rs. 5169146.00.
